Nanogel-Based Drug Delivery: Tailoring BMP-2 Release for Bone Regeneration

dc.contributor.advisorLowe, Tao
dc.contributor.authorUmansky, Sophie
dc.contributor.authorMirdamadi, Eman
dc.contributor.authorWhite, Cameron
dc.contributor.authorLowe, Hannah
dc.date.accessioned2025-06-04T15:54:16Z
dc.date.issued2025
dc.description.abstractCritical sized bone defects (CSBDs) do not heal spontaneously, requiring medical intervention. Continuous bone morphogenetic protein-2 (BMP-2) delivery to an injured site is necessary for CSBD regeneration. However, direct BMP-2 delivery is ineffective due to the protein’s short half-life. Nanogels can be used to encapsulate and sustain bioactive BMP-2 release for long time periods. In this study, novel BMP-2 loaded nanogels composed of thermosensitive poly(N-isopropylacrylamide) (PNIPAAm) and hydrolytically degradable dextran-poly(lactate (PLA)-2-hydroxyethyl-methacrylate) or dextran-poly(caprolactone (PCL)-2-hydroxyethyl-methacrylate) macromer were synthesized using emulsion polymerization. Macromers containing PCL or PLA with different degrees of substitution and degree of polymerization (DP/DS), 6/3.8, 6/2.49, 8/3.73 and 8/4.7 were used during synthesis. All nanogels load BMP-2 with approximately 90% encapsulation efficiencies, and range in hydrodynamic diameter between 80 and 196 nm with increasing DP and DS. In vitro BMP-2 release from the nanogels were carried out for 18 days, and released BMP-2 was quantified by ELISA. Among nanogels sustain releasing BMP-2, PCL macromer nanogels with a DP/DS of 6/3.8 had the slowest overall cumulative BMP-2 release, while BMP-2-loaded nanogels containing PLA macromers showed the slowest release with increasing DP and/or DS. Nanogel vehicle cytotoxicity to dental pulp stem cells (DPSCs) was tested using MTT and showed that nanogels were not cytotoxic to DPSCs at concentrations up to 5mg/mL. Overall, the nanogel systems demonstrate a promising approach to sustain BMP-2 release with tailored release kinetics for CSBD regeneration.
dc.description.sponsorshipARCS® Foundation Metro Washington Chapter Maryland Stem Cell Research Fund (MSCRF) Validation Award 2023-MSCRFV-6020 Frederick G. Smith, MS, DDS and Venice K. Paterakis, DDS Endowment Fund
dc.identifierhttps://doi.org/10.13016/e3ht-1f8v
dc.identifier.urihttp://hdl.handle.net/1903/33903
dc.language.isoen_US
dc.subjectBioengineering
dc.subjectBiomaterials
dc.subjectNanoparticles
dc.subjectENGR
dc.titleNanogel-Based Drug Delivery: Tailoring BMP-2 Release for Bone Regeneration
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2025_URD_Umansky_Sophie.pdf
Size:
422.75 KB
Format:
Adobe Portable Document Format